SCHEMBL22338178

SCHEMBL22338178

O=C(O)NCC(C(=O)O)c1ccc(F)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGFR P43088 3/20 0.46
HDAC3 O15379 1/20 0.42
HDAC4 P56524 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC10 Q969S8 1/20 0.42
HDAC11 Q96DB2 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
HDAC9 Q9UKV0 1/20 0.42
HDAC5 Q9UQL6 1/20 0.42
EGLN2 Q96KS0 1/20 0.41
EGLN1 Q9GZT9 1/20 0.41
CNR2 P34972 1/20 0.41
MME P08473 1/20 0.39
PTGS1 P23219 1/20 0.39
PTGS2 P35354 1/20 0.39
CACNA1B Q00975 2/20 0.39
ALDH1A1 P00352 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4325567 0.84 ESR1 (0.44) CNR2PTGS1PTGS2ALDH1A1KDM4E
SCHEMBL4333359 0.83 CYP2C19 (0.52) PTGFRALDH1A1MAPK1
SCHEMBL28290228 0.83 CYP2C19 (0.52) PTGFRALDH1A1MAPK1
SCHEMBL29182140 0.82 NPC1 (0.54) PTGFREGLN2EGLN1ALDH1A1SLC6A9
SCHEMBL20430458 0.80 BCAT2 (0.51) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL5751931 0.80 BCAT2 (0.51) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL30371988 0.79 PTGS1 (0.44) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL25045524 0.79 CTSS (0.46) PTGFREGLN2EGLN1MME
SCHEMBL4065435 0.79 HDAC3 (0.42) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL15663752 0.79 HDAC3 (0.42) HDAC3HDAC4HDAC1HDAC7HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020161257-A1 3-AMINO-2-[2-(ACYLAMINO)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE AS CSNK1 INHIBITORS BAYER AKTIENGESELLSCHAFT (DE) 2020-08-13 WO disclosed